The Retifanlimab cardRetifanlimab

Retifanlimab

Common

Rarity: Common

The most frequent rarity: most Wikipedia articles become Commons.

Rarity follows how well known the article is: its views on the French and English Wikipedia over a year, and the number of languages it exists in.

At a glance

Class
Invention
Domain
Science and technology
Knowledge cost
1
In collections
Nobody has pulled it yet.

What Wikipedia says

Retifanlimab, sold under the brand name Zynyz, is an anti-cancer medication used for the treatment of Merkel cell carcinoma. Retifanlimab is a programmed death receptor-1 (PD-1)–blocking monoclonal antibody.

Excerpt from the Wikipedia article “Retifanlimab”, under the CC BY-SA 4.0 license. Read the article on Wikipedia

Image: Laboratoires Servier, CC BY-SA 3.0, via Wikimedia Commons.

Open free boosters and add Retifanlimab to your collection.

Play for free

Related cards